FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33569711000001103: Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Nov 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1238371000001113 Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1238381000001110 Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Is a Quetiapine 150mg modified-release tablets true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has active ingredient Quetiapine true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient Quetiapine fumarate true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Is a Brancico XL true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Has basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) 60 tablet 6 x 10 tablets Has AMP True Brancico XL 150mg tablets (Zentiva Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start